Omeros (OMER) Gross Margin Growth (5y) (2019 - 2026)

Omeros (OMER) Gross Margin Growth (5y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -468.00
Dec 31, 2021 4,011.00
Sep 30, 2021 224.00
Jun 30, 2021 208.00
Mar 31, 2021 316.00
Dec 31, 2020 543.00
Sep 30, 2020 607.00
Jun 30, 2020 1,037.00
Mar 31, 2020 170.00
Dec 31, 2019 -120.00
Sep 30, 2019 -93.00
Jun 30, 2019 -21.00
Mar 31, 2019 -60.00